IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 129 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $328,000 | -15.5% | 25,300 | 0.0% | 0.03% | -15.2% |
| Q2 2014 | $388,000 | +24.4% | 25,300 | 0.0% | 0.03% | +22.2% |
| Q1 2014 | $312,000 | +6.1% | 25,300 | 0.0% | 0.03% | +28.6% |
| Q4 2013 | $294,000 | -2.0% | 25,300 | 0.0% | 0.02% | -22.2% |
| Q3 2013 | $300,000 | +19.5% | 25,300 | 0.0% | 0.03% | -44.9% |
| Q2 2013 | $251,000 | – | 25,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |